Anthracycline-induced cardiotoxicity in patients with paediatric bone sarcoma and soft tissue sarcoma

E-ISSN： 1467-1107|27|9|1815-1822

ISSN： 1047-9511

Source： Cardiology in the Young, Vol.27, Iss.9, 2017-08, pp. : 1815-1822

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Soft tissue sarcoma

By Peiper Matthias Gerber Peter Arne Engers Rainer Matuschek Christiane Budach Wilfried Gripp Stephan Pape Hildegard Orth Klaus Bölke Edwin

Wiener klinische Wochenschrift, Vol. 120, Iss. 23-24, 2008-12 ,pp. : 732-732

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy for soft tissue sarcoma

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 2952-2960

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 257-261

Karger

Access to resources Recommend Favorite

Is There an Indication for High-Dose Chemotherapy in the Treatment of Bone and Soft-Tissue Sarcoma?

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 115-121

Karger

Access to resources Recommend Favorite

Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005)

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 4, 2018-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite